Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Citius Pharmaceuticals Inc (NASDAQ: CTXR)

 
CTXR Technical Analysis
4
As on 3rd Jul 2025 CTXR STOCK Price closed @ 2.21 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.81 & Strong Buy for SHORT-TERM with Stoploss of 0.74 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

CTXRSTOCK Price

Open 2.07 Change Price %
High 2.48 1 Day 0.11 5.24
Low 1.99 1 Week 0.92 71.32
Close 2.21 1 Month 1.47 198.65
Volume 2798902 1 Year 1.46 194.67
52 Week High 4.37 | 52 Week Low 0.13
 
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
LCID 2.16 5.37%
HCTI 0.03 50.00%
NVDA 159.34 1.33%
LMDX 0.02 0.00%
AKTS 0.04 0.00%
PLUG 1.47 5.00%
WINT 0.93 20.78%
BTBT 2.94 11.79%
LILM 0.05 0.00%
 
NASDAQ USA Top Gainers Stocks
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
TBIO 0.30 500.00%
NBSTU 12.99 220.74%
NDRAW 0.03 200.00%
HCVIU 9.00 159.37%
GLSPT 33.43 138.62%
BIOC 0.07 133.33%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
CTHR 0.22 -77.08%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
AXAS 0.03 -70.00%
BPTH 0.21 -66.67%
AXDX 0.03 -66.67%
TFFP 0.06 -62.50%
HEPA 0.12 -62.50%
 
 
CTXR
Daily Charts		 CTXR
Intraday Charts		 Whats New @
Bazaartrend		 CTXR
Free Analysis
 
CTXR Important Levels Intraday
RESISTANCE3.15
RESISTANCE2.85
RESISTANCE2.66
RESISTANCE2.48
SUPPORT1.94
SUPPORT1.76
SUPPORT1.57
SUPPORT1.27
 
CTXR Forecast July 2025
Share
4th UP Forecast2.71
3rd UP Forecast2.55
2nd UP Forecast2.45
1st UP Forecast2.35
1st DOWN Forecast2.07
2nd DOWN Forecast1.97
3rd DOWN Forecast1.87
4th DOWN Forecast1.71
 
CTXR Weekly Forecast
4th UP Forecast2.46
3rd UP Forecast2.38
2nd UP Forecast2.33
1st UP Forecast2.28
1st DOWN Forecast2.14
2nd DOWN Forecast2.09
3rd DOWN Forecast2.04
4th DOWN Forecast1.96
 
CTXR Forecast2025
4th UP Forecast13.46
3rd UP Forecast9.85
2nd UP Forecast7.62
1st UP Forecast5.39
1st DOWN Forecast-0.97
2nd DOWN Forecast-3.2
3rd DOWN Forecast-5.43
4th DOWN Forecast-9.04
 
 
CTXR Other Details
Segment EQ
Market Capital 278819904.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
CTXR Address
CTXR
 
CTXR Latest News
 
Your Comments and Response on Citius Pharmaceuticals Inc
 
CTXR Business Profile
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes critical care products targeting medical needs with a focus on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing four proprietary products, including Mino-Lok, an antibiotic lock solution used to treat patients with catheter-related bloodstream infections by salvaging the infected catheter; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a corticosteroid-lidocaine topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; and NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory disease syndrome. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey. Address: 11 Commerce Drive, Cranford, NJ, United States, 07016
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service